Literature DB >> 17418754

Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.

John G T Augoustides1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17418754     DOI： 10.1053/j.jvca.2007.01.002

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  3 in total

1.  Perioperative safety of aprotinin in coronary artery bypass graft surgery: is there life after BART?

Authors:  John G Augoustides
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta: a propensity score matched case-control study.

Authors:  Won Ho Kim; Mi Hye Park; Hyo-Jin Kim; Hyun-Young Lim; Haeng Seon Shim; Ju-Tae Sohn; Chung Su Kim; Sangmin M Lee
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 3.  Prediction and Prevention of Acute Kidney Injury after Cardiac Surgery.

Authors:  Su Rin Shin; Won Ho Kim; Dong Joon Kim; Il-Woo Shin; Ju-Tae Sohn
Journal:  Biomed Res Int       Date:  2016-06-23       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.